Researchers investigated the effect of SARS-CoV-2 spike (S) protein subunit 1 (S1) on the pulmonary endothelium.
Shifting the paradigm – novel approaches to amyotrophic lateral sclerosis therapy – Pharmaceutical Technology
Share this article The high failure rate in ALS clinical trials is often attributed to the disease’s unclear aetiology and complex pathophysiology. Credit: CC7 via